^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

FT576

i
Other names: iPSC-derived, multi-antigen targeted CAR-BCMA NK cell therapy, FT576
Associations
Trials
Company:
Fate Therap
Drug class:
CD38 inhibitor, BCMA inhibitor
Associations
Trials